Headlands Technologies LLC United Therapeutics Corp Transaction History

Headlands Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$210.76 - $249.51 $83,250 - $98,556	395 Added 53.67%	1,131 $259,000
Q4 2023 Feb 02, 2024	SELL	$214.88 - $256.94 $267,525 - $319,890	-1,245 Reduced 62.85%	736 $161,000
Q3 2023 Nov 09, 2023	SELL	$211.82 - $248.24 $120,313 - $141,000	-568 Reduced 22.28%	1,981 $447,000
Q2 2023 Aug 03, 2023	BUY	$205.19 - $232.99 $512,564 - $582,009	2,498 Added 4898.04%	2,549 $562,000
Q1 2023 May 01, 2023	SELL	$212.99 - $276.17 $126,729 - $164,321	-595 Reduced 92.11%	51 $11,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $133,043 - $181,157	646 New	646 $180,000

618

45M

368K

410K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.